Aspira Women's Health Statistics
Share Statistics
Aspira Women's Health has 35.22M
shares outstanding. The number of shares has increased by 41.97%
in one year.
| Shares Outstanding | 35.22M |
| Shares Change (YoY) | 41.97% |
| Shares Change (QoQ) | 6.05% |
| Owned by Institutions (%) | 6.4% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 18,000 |
| FTD / Avg. Volume | 0.38% |
Short Selling Information
The latest short interest is 252.93K, so 1.44% of the outstanding
shares have been sold short.
| Short Interest | 252.93K |
| Short % of Shares Out | 1.44% |
| Short % of Float | 1.79% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.76 and the forward
PE ratio is -0.32.
Aspira Women's Health's PEG ratio is
0.02.
| PE Ratio | -0.76 |
| Forward PE | -0.32 |
| PS Ratio | 1.09 |
| Forward PS | 0 |
| PB Ratio | -3.89 |
| P/FCF Ratio | -0.82 |
| PEG Ratio | 0.02 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Aspira Women's Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76,
with a Debt / Equity ratio of -1.08.
| Current Ratio | 0.76 |
| Quick Ratio | 0.71 |
| Debt / Equity | -1.08 |
| Debt / EBITDA | -0.17 |
| Debt / FCF | -0.23 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $139,121.21 |
| Profits Per Employee | $-198,393.94 |
| Employee Count | 66 |
| Asset Turnover | 1.67 |
| Inventory Turnover | 11.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -97.6% in the
last 52 weeks. The beta is 2.01, so Aspira Women's Health's
price volatility has been higher than the market average.
| Beta | 2.01 |
| 52-Week Price Change | -97.6% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.7 |
| Relative Strength Index (RSI) | 23.78 |
| Average Volume (20 Days) | 4,780,901 |
Income Statement
In the last 12 months, Aspira Women's Health had revenue of 9.18M
and earned -13.09M
in profits. Earnings per share was -0.93.
| Revenue | 9.18M |
| Gross Profit | 5.48M |
| Operating Income | -16.28M |
| Net Income | -13.09M |
| EBITDA | -16.19M |
| EBIT | -16.28M |
| Earnings Per Share (EPS) | -0.93 |
Full Income StatementBalance Sheet
The company has 1.77M in cash and 2.76M in
debt, giving a net cash position of -993K.
| Cash & Cash Equivalents | 1.77M |
| Total Debt | 2.76M |
| Net Cash | -993K |
| Retained Earnings | -531.4M |
| Total Assets | 5.49M |
| Working Capital | -1.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -12.11M
and capital expenditures -37K, giving a free cash flow of -12.15M.
| Operating Cash Flow | -12.11M |
| Capital Expenditures | -37K |
| Free Cash Flow | -12.15M |
| FCF Per Share | -0.86 |
Full Cash Flow StatementMargins
Gross margin is 59.67%, with operating and profit margins of -177.28% and -142.61%.
| Gross Margin | 59.67% |
| Operating Margin | -177.28% |
| Pretax Margin | -142.61% |
| Profit Margin | -142.61% |
| EBITDA Margin | -176.28% |
| EBIT Margin | -177.28% |
| FCF Margin | -132.32% |
